WO2007055355A1 - Contenant a plusieurs compartiments - Google Patents

Contenant a plusieurs compartiments Download PDF

Info

Publication number
WO2007055355A1
WO2007055355A1 PCT/JP2006/322564 JP2006322564W WO2007055355A1 WO 2007055355 A1 WO2007055355 A1 WO 2007055355A1 JP 2006322564 W JP2006322564 W JP 2006322564W WO 2007055355 A1 WO2007055355 A1 WO 2007055355A1
Authority
WO
WIPO (PCT)
Prior art keywords
bag
storage bag
medicine storage
medicine
opening
Prior art date
Application number
PCT/JP2006/322564
Other languages
English (en)
Japanese (ja)
Inventor
Shoji Igota
Kaoru Shimizu
Original Assignee
Ajinomoto Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co., Inc. filed Critical Ajinomoto Co., Inc.
Priority to JP2007544218A priority Critical patent/JP4962733B2/ja
Publication of WO2007055355A1 publication Critical patent/WO2007055355A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2024—Separating means having peelable seals

Definitions

  • the internal cavity is separated by the weak seal portion, thereby forming a plurality of compartments for individually storing and storing the drug, and opening the weak seal portion during use.
  • the present invention relates to a multi-chamber container that is mixed and discharged.
  • multi-liquid mixing type multi-chamber containers for infusion and dialysis.
  • a multi-chamber container the internal cavity of a medicine bag made of a soft film is separated into a plurality of compartments each containing a different chemical solution by a weak seal.
  • the outer periphery of the medicine storage bag is provided with a chemical liquid discharge port as a rigid plastic molded product capable of maintaining its shape, the chemical liquid discharge port is formed in a cylindrical shape, and the internal cavity is at one end on one side. Force opening to the chamber The other end has a rubber stopper.
  • the weak seal part Prior to administration of the drug solution to the patient, the weak seal part is opened by applying external force to the drug storage bag, and the internal cavity of the drug storage bag becomes a single chamber.
  • the puncture needle can be used to puncture a rubber stopper, allowing the drug solution to be administered from the drug storage bag. Therefore, in this type of multi-chamber container, it is essential to open the weak seal part by mixing the two liquids prior to the administration of the chemical liquid. On the other hand, it is necessary to discharge the chemical liquid without opening the weak seal part.
  • the rubber stopper was punctured at the outlet, there was a possibility of an erroneous operation in which only the drug solution in the compartment on the drug solution outlet side was administered.
  • a second weak seal portion is provided immediately before the chemical solution discharge port.
  • the second weak seal part is placed next to the first weak seal part. It has been proposed to open the doors in order so that discharge is performed after mixing of the chemicals (see Patent Document 1).
  • Patent Document 1 Japanese Patent Laid-Open No. 9 327498
  • a second weak seal portion is provided immediately before the chemical solution outlet, and these weak seal portions are sequentially opened.
  • the strength of trying to prevent the administration of unmixed chemicals is provided with two weak seals, which complicates the manufacturing process and makes it very difficult to accurately manufacture multiple weak seals with different strengths. This is a difficult task, increases costs, and forces the user to perform two-stage pressurization work, which is always good for workability.
  • the first weak seal part ⁇ the second weak seal part may not always be opened, but the second weak seal part on the chemical solution outlet side is not necessarily opened. If the part is opened first, there is a possibility of shifting to the administration work as it is, and in this case, only one solution is administered without mixing.
  • the present invention has been made in view of the above-mentioned problems. Administration is performed in an unopened state, and a novel structure of a multi-chamber container is provided. The purpose is to more surely eliminate the possibility of erroneous operation in which administration is performed in an unmixed state despite good side workability.
  • the mixed drug-sealed bag-like material includes a drug storage bag formed of a flexible film, a discharge port for discharging the drug, and an internal cavity of the drug storage bag.
  • a weak seal portion that separates into a plurality of compartments for storing the medicines, is opened by a pressing force applied to the medicine storage bag from the outside, and mixes the medicines stored in the respective compartments. It is equipped with.
  • the sealing bag which is formed of a flexible film that is more fragile than the flexible film that constitutes the medicine storage bag and is located inside the medicine storage bag, is provided in the space between the medicine storage bag and the inner space of the medicine storage bag.
  • the outlet is surrounded and disposed so as to close the open end to the chamber, and the inner surface of the medicine storage bag is welded and joined to the opposite outer surface of the sealing bag at a small area to form an opening portion, and the pressing at the time of opening is performed.
  • the sealing bag is broken at the opening, the discharge port is opened in the internal cavity of the drug storage bag, and the mixed drug is discharged from the discharge port.
  • the discharge port is normally closed by a sealing bag inside the medicine storage bag, and the sealing bag is firmly welded and joined to the opposite surface of the medicine storage bag at the opening portion as a small area portion. . Therefore, by appropriately selecting the material and thickness of the synthetic resin film constituting the sealing bag, the size of the opening portion, the shape of the opening portion, etc., the internal fluid pressure during the mixing operation can reliably destroy only the sealing bag. Thus, the mixed drug can be discharged from the discharge port.
  • the separation seal (weak seal) that should be mixed with the two liquids and the opening part that prevents the administration of the mixed drug to be opened by a separate mechanism can achieve reliable “step-by-step” communication. It is.
  • FIG. 1 is a plan view of the multi-chamber container of the present invention (a view taken in the direction of arrow I in FIG. 2).
  • FIG. 2 is a cross-sectional view of the multi-chamber container of the present invention, and is a view taken along the line II-II in FIG.
  • FIG. 3 is a partial view of the vicinity of the discharge port in FIG. 2 and schematically shows the state when the multi-chamber container of the present invention is opened.
  • FIG. 4 is a schematic view showing an example of a point seal method in a series of steps.
  • FIG. 5 is a schematic view showing another example of the point sealing method in FIG. 4 in a series of steps.
  • FIG. 6 shows a discharge port with an internal bag mounted with a point seal support plate.
  • FIG. 7 is a perspective view schematically showing a state in which the point seal support plate is attached to the discharge port in FIG.
  • FIG. 8 shows the vicinity of the discharge port of the multi-chamber container in another embodiment in which the opposing surfaces of the drug storage bag 10 and the inner bag 13 are connected by a substantially full-width heat seal portion in addition to the point seal.
  • the multi-chamber container is a flat medicine storage bag (external bag) 10 for storing medicine, a discharge port 12 fixed to the outer periphery of the medicine storage bag 10, and a medicine.
  • a force is also configured with a small-capacity sealing bag (inner bag) 13 that seals the outlet 12 in the normal state against the inner cavity of the storage bag 10.
  • the drug storage bag 10 is made of a soft film (a flexible material of the present invention) having a multilayer structure such as a polypropylene film or a polyethylene film having a thickness of 200 microns.
  • This medicine storage bag 10 can be a bag made of tube-like inflation film or a container made of blow-molded bag, in addition to the above-described bag-making from a film.
  • a suspension hole 16 is formed in the strong seal portion 14, and the medicine storage bag 10 is suspended and held by the suspension hole 16 on an infusion stand or the like to perform infusion or dialysis.
  • the weak seal portion 18 is formed by pressurizing the front and back surfaces of the synthetic resin film section forming the drug storage bag 10 at a low temperature (110 ° C. in the case of polypropylene) slightly higher than its softening temperature.
  • the strong seal portion 14 remains as it is by pressurizing the drug solution in the drug storage bag 10 from the outside in the compartments 20 and 22 while the respective drug solutions are stored in the first compartment 20 and the second compartment 22.
  • the weak seal portion 18 can be broken and opened by fluid pressure (pressure of the chemical solution during pressurization) to mix the first chemical solution and the second chemical solution.
  • the discharge port 12 is made of a synthetic resin having a thickness and rigidity capable of maintaining its form (the same plastic material as the drug storage bag 10 is used to obtain adhesion to the drug storage bag 10). (Preferred).
  • the discharge port 12 is formed in a cylindrical shape having openings at both ends, the middle forming a tapered portion 12-1, and the upper end having a flange portion 12-2 (FIG. 1).
  • the cap 12-3 is abutted and welded to the flange 12-2, and the rubber inner lid 12-4 (the plug of the present invention) is attached to the bottom opening of the cap 12-3.
  • the inner lid 12-4 is punctured by the puncture needle of the infusion set, and the inner cavity of the medicine storage bag 10 is communicated with the infusion tube to perform infusion.
  • the synthetic resin film that forms the front and back surfaces of the medicine storage bag 10 is moved up and down the cylindrical portion of the discharge port 12 through the synthetic resin film that forms the front and back surfaces of the sealing bag 13. Heating and adhering while sandwiching, the medicine storage bag 10 is sealed with respect to the discharge port 12.
  • the small-capacity sealing bag 13 is provided inside the medicine storage bag 10 and is provided to seal the discharge port 12 in a normal state.
  • the sealing bag 13 is similar to the drug storage bag 10 in that the upper and lower synthetic resin film sections, such as polypropylene film and polyethylene film, are heated at the outer peripheral portion 13A (the welding temperature of the strong seal portion 14 of the drug storage bag 10). It is formed by welding at the same temperature), but as described later, it is sealed so that it can be ruptured at the point seal part by opening the medicine storage bag 10 by the fluid pressure when opening the weak seal 18.
  • the synthetic resin film constituting the stopper bag 13 is considered to be weaker than the synthetic resin film constituting the drug storage bag 10 in terms of strength.
  • the inner and outer bags are made of the same synthetic resin material.
  • the thickness can be made appropriately thinner than that of the synthetic resin film constituting the medicine storage bag 10.
  • the required strength difference between the inner and outer bags can be reduced by making the polymerization degree of the synthetic resin constituting the drug storage bag 10 smaller than the polymerization degree of the synthetic resin constituting the sealing bag 13 or by using a copolymer.
  • the sealing bag 13 is sterilized under the heat and humidity in the sealing bag 13 by assembling a microscopic hole through which a liquid having a flow rate very slow compared to the drip rate can pass (aseptic sterilization). ) It is advantageous for operation.
  • the sealing bag 13 has a width that is somewhat larger than the outer diameter of the discharge port 12 and extends toward the internal cavity of the drug storage bag 10 when the drug storage bag 10 is not opened.
  • the sealing bag 13 is attached to the discharge port 12 together with the medicine storage bag 10 as described later. That is, the strong seal portion 14 on the outer periphery of the medicine storage bag 10 is welded to the outer periphery of the discharge port 12 in the portion 14-1, and the outer peripheral portion 13-1 of the sealing bag 13 is also overlapped and welded at the time of this welding. (See Figure 2).
  • the sealing bag 13 is normally closed with respect to the internal cavity (compartment 22) of the medicine storage bag 10, that is, when the weak seal portion 18 is not opened, the medicine in the medicine storage bag 10 is closed. Is blocked from going to the outlet 12.
  • the outer surface of the sealing bag 13 is welded (point-sealed) to the opposing inner surface (upper and lower inner surfaces) of the medicine storage bag 10 with a small area portion 30.
  • This small area portion 30 where the outer surface of the sealing bag 13 is welded to the opposite inner surface of the drug storage bag 10 has a rectangular shape with a sharp corner as shown by the hatched area in FIG.
  • the temperature is as high as the welding temperature of the strong seal portion 14 on the outer periphery of the drug storage bag 10.
  • the medicine storage bag 10 When the weak seal portion 18 is opened, the medicine storage bag 10 is expanded, and the sealing bag 13 whose outer surface is welded to the opposite inner surface of the medicine storage bag 10 with a small area portion 30 receives a tensile force in the vertical direction and is small. Since the welding of the area portion 30 is strong, a tearing force is generated in the sealing bag 13, and the synthetic resin film constituting the sealing bag 13 is stronger than the synthetic resin film constituting the drug storage bag 10. There is also the effect of stress concentration caused by the weak and sharp shape of the small area part 30. As the drug storage bag 10 is expanded, the sealing bag 13 is strongly bowed at the point seal part 30 as shown in Fig. 3.
  • the sealing bag 13 is It is ruptured at the into-seal portion 30 and the discharge port 12 is opened, so that the chemical solution can be discharged. That is, in order to open the medicine storage bag 10, the medicine storage bag 10 is placed flat on a desk or the like as shown in FIG. 2, and the medicine storage bag 10 is pressurized with a palm from the top as shown by an arrow b ( As shown in FIG. 3, it is preferable to pressurize the medicine storage bag 10 on the compartment 20 side, but the compartment 22 side may be pressurized or both sides may be pressurized. By pressurizing the medicine storage bag 10, a hydraulic pressure is applied to the weak seal portion 18, and the weak seal portion 18 is instantaneously broken and opened by a predetermined pressure.
  • the internal pressure of the medicine storage bag 10 is increased by pressurization, and this increased pressure is released at once by opening and closing the weak seal portion 18, so that a shocking flow of the chemical solution flows into the medicine storage bag 10. Induced.
  • FIG. 3 the flow of the shocking chemical liquid induced in the medicine storage bag 10 is schematically shown by an arrow F.
  • the rapid flow F of the chemical solution induced in the medicine storage bag 10 when the weak seal portion 18 is opened causes the medicine storage bag 10 to be greatly expanded as shown in FIG. Therefore, a large tearing force is generated in the small-capacity sealing bag 13 firmly welded to the opposite surface of the medicine storage bag 10 at the small area portion 30, and the synthetic resin film constituting the sealing bag 13.
  • the point seal portion of the sealing bag 30 is torn while it is welded to the medicine storage bag 10 as shown by 13 '.
  • an opening 40 is formed in the sealing bag 13, and the medicine opens as indicated by an arrow.
  • the rubber plug 12-3 is punctured with a puncture needle of an infusion set (not shown) to discharge the mixed drug solution. It becomes possible.
  • the opening of the isolation seal (weak seal 18) to be mixed with the two liquids and the opening of the opening (point seal 30) for preventing the administration of the mixed drug are said to be “stepwise”. ⁇ Because of the opening structure, it is possible to achieve reliable communication during opening work.
  • the acute rectangular shape of the small area portion 30 can contribute to causing the sealing bag 13 to burst more reliably due to the stress concentration effect. Then, by optimally setting the composition and thickness of the synthetic resin film constituting the sealing bag 13, the medicine to the outlet 12 when the medicine storage bag is not opened (when the weak seal 18 is closed) is used. Inflow prevention (maintaining the closed state of the outlet / outlet 12 by the sealing bag 13), while the drug storage bag is opened (when the weak seal 18 is opened) It can be discharged Can be done.
  • the upper and lower synthetic resin films forming the medicine storage bag 10 are arranged on the outer periphery as shown in (a).
  • the strong seal portion 14 is not welded at the portion 14A, and an opening is exhibited at the unwelded portion.
  • the sealing bag 13 is already stored in the medicine storage bag 10, and the outer peripheral portion 13A is temporarily welded inside the opening portion 14A of the outer bag leaving an opening in the mounting portion 13B of the discharge port 12.
  • a welding tool receiver is inserted toward the unsealed opening 13B of the sealing bag 13, and point sealing is performed with the external welding tool. That is, the welding tool having a welded part shape conforming to the shape of the point seal part and the receiver are brought into contact with each other via the film slice constituting the drug storage bag 10 and the film slice constituting the sealing bag 13, and the drug Point seal (high temperature welding at small area 30) between inner surface of storage bag 10 and outer surface of sealing bag 13 is performed
  • the discharge port 12 is inserted toward the non-welding opening of the sealing bag 13 as indicated by the arrow f in (b), and welding is performed from the outside of the medicine storage bag 10. Therefore, the unsealed portion 14A of the synthetic resin film section constituting the medicine storage bag 10 is heat-pressed against the outer periphery of the discharge port 12 through the unsealed portion of the synthetic resin film constituting the sealing bag 13. The sealing bag 10 is welded to the discharge port 12 through the sealing bag 13.
  • (0018) (c) shows the state after the discharge port 12 is welded. In this state, the weak seal portion 18 shown in FIG. 1 is welded and the compartments 20 and 22 are filled with chemicals and the filling port is sealed. The multi-chamber container of the present invention is completed.
  • FIG. 5 shows a point seal method according to another embodiment.
  • a sealed bag 13 having a welded seal bag 13 is first prepared as a discharge port 12.
  • the medicine storage bag 10 has an unwelded portion 14A left on the outer peripheral strong seal portion 14, and this unwelded portion forms an opening, and the sealing bag 13 is stored in the medicine through the unsealed opening. Insert into bag 10 (Fig. 5 (b)). Then, the unwelded portion 14B is welded to the discharge port 12, and the strong seal portion 14 on the entire circumference is completed. Then, as shown in (c), point sealing is performed, and the medicine storage bag 10 and the sealing bag 13 are welded at a rectangular small area portion 30 on the opposing surface.
  • the welding tool is arranged so that the medicine storage bag 10 and the inner sealing bag 13 are sandwiched from the outside, and the welding tool is crimped via the inner and outer bags, so that the inner surface of the medicine storage bag 10 and the medicine storage bag It is performed so that 10 outer surfaces are welded in a small area.
  • the discharge port 12 is provided with a point seal receiving plate 50 protruding into the internal cavity of the sealing bag 13 as shown in FIG. Can be used.
  • the point seal tool receiving plate 50 is somewhat wider than the inner diameter of the discharge port 12, and includes a substrate portion 50-1 and a receiving plate portion 50-2 orthogonal to the substrate portion 50-1.
  • the part 50-1 is press-fitted and fixed to a groove part 52 formed in the diameter opposite position on the inner diameter part of the discharge port 12.
  • the point seal device receiving plate 50 is made of a material that is difficult to weld to the synthetic resin film constituting the inner and outer nogs.
  • Point sealing is performed so that the medicine storage bag 10 and the inner bag 13 are sandwiched by the welding tool from the outside via the receiving plate portion 50-2. Therefore, it is possible to efficiently perform point sealing in a small area between the inner surface of the drug storage bag 10 and the outer surface of the inner sealing bag 13, and a sufficient flow path for the drug is secured because a gap remains. can do
  • the force at which the opposing surfaces of the medicine storage bag 10 and the inner bag 13 are connected only by a point seal is added to the discharge port 12 in addition to the point seal 30.
  • the heat seal portion 42 is not torn or difficult to break. Therefore, the inner bag 13 remains joined to the drug storage bag 10 as a whole, that is, the inflated bag shape is maintained and only the portion of the point seal 30 is opened.
  • the hollow force can also ensure a smooth flow of the chemical solution toward the discharge port 12 through the inner bag 13 through the opening where the point seal 30 is broken.
  • the medicine storage bag 10 and the inner bag 13 are joined to each other by a pair of point seals 30 on the upper and lower opposing surfaces.
  • the point seal 30 that joins the opposing surfaces of the hook 13 is provided only on one of the upper and lower surfaces in FIG. 2, and the other opposing surface is a heat seal part that covers substantially the entire width where stress concentration is unlikely to occur. You may make it join by.
  • the drug storage bag 10 is opened only by rupturing only the point seal on one side, and the other heat seal is not ruptured. Since the opposite surfaces of 13 remain bonded, the inner bag 13 is not easily crushed as in FIG. 8, and the smooth chemical flow through the opening formed by the tear at the point seal portion is the same. 1 ⁇ 2 can be kept.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Package Specialized In Special Use (AREA)

Abstract

La présente invention concerne un sac de rangement de médicaments (10) constitué d'un matériau de film de résine synthétique souple, dont l'espace interne est divisé en plusieurs compartiments (20, 22) par une partie de scellement faible (18) et dans lequel une ouverture de déchargement (12) est formée de manière à s'ouvrir vers un compartiment (20). Un sac de scellement (13) de petite capacité est prévu dans le sac de rangement de médicaments (10) de sorte que le sac de scellement (13) ferme l'ouverture de déchargement (12) vers l'espace intérieur du sac de rangement de médicaments (10). Un film de résine synthétique plus fragile que le film de résine synthétique constituant le sac de rangement de médicaments (10) est choisi comme matériau constituant le sac de scellement (13). La face interne du sac de rangement de médicaments (10) est fortement liée par fusion à la face interne du sac de scellement (13) sur une partie rectangulaire qui possède une forme de coin aigu avec une petite surface. Lorsque la partie de scellement faible est descellée, le sac extérieur est agrandi du fait d'une pression fluidique qui lui est appliquée, ce qui entraîne l'éclatement et l'ouverture du sac interne.
PCT/JP2006/322564 2005-11-14 2006-11-13 Contenant a plusieurs compartiments WO2007055355A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007544218A JP4962733B2 (ja) 2005-11-14 2006-11-13 複室容器

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005328592 2005-11-14
JP2005-328592 2005-11-14

Publications (1)

Publication Number Publication Date
WO2007055355A1 true WO2007055355A1 (fr) 2007-05-18

Family

ID=38023347

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/322564 WO2007055355A1 (fr) 2005-11-14 2006-11-13 Contenant a plusieurs compartiments

Country Status (2)

Country Link
JP (1) JP4962733B2 (fr)
WO (1) WO2007055355A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009000343A (ja) * 2007-06-22 2009-01-08 Ajinomoto Co Inc 複室容器
US8617133B2 (en) 2007-07-17 2013-12-31 Ajinomoto Co., Inc. Multi-chamber container
WO2019086251A1 (fr) * 2017-11-06 2019-05-09 Calbact Ag Calorimètre et récipient à échantillon pour calorimètre

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003305107A (ja) * 2002-02-14 2003-10-28 Otsuka Pharmaceut Factory Inc 薬剤排出部材及び医療用複室容器
JP2005028040A (ja) * 2003-07-11 2005-02-03 Medicalseed:Kk 隔壁バッグ用封止栓
WO2005097039A1 (fr) * 2004-04-08 2005-10-20 Ajinomoto Co., Inc. Corps fermé contenant des médicaments

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003305107A (ja) * 2002-02-14 2003-10-28 Otsuka Pharmaceut Factory Inc 薬剤排出部材及び医療用複室容器
JP2005028040A (ja) * 2003-07-11 2005-02-03 Medicalseed:Kk 隔壁バッグ用封止栓
WO2005097039A1 (fr) * 2004-04-08 2005-10-20 Ajinomoto Co., Inc. Corps fermé contenant des médicaments

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009000343A (ja) * 2007-06-22 2009-01-08 Ajinomoto Co Inc 複室容器
US8617133B2 (en) 2007-07-17 2013-12-31 Ajinomoto Co., Inc. Multi-chamber container
WO2019086251A1 (fr) * 2017-11-06 2019-05-09 Calbact Ag Calorimètre et récipient à échantillon pour calorimètre
CN111194400A (zh) * 2017-11-06 2020-05-22 卡尔巴科特公司 量热计和用于量热计的样品容器
CN111194400B (zh) * 2017-11-06 2022-02-11 卡尔巴科特公司 量热计和用于量热计的样品容器
US11480534B2 (en) 2017-11-06 2022-10-25 Calbact Ag Calorimeter and sample container for a calorimeter

Also Published As

Publication number Publication date
JPWO2007055355A1 (ja) 2009-04-30
JP4962733B2 (ja) 2012-06-27

Similar Documents

Publication Publication Date Title
JP3316577B2 (ja) 剥離可能シール、ならびに同シールを備える容器
KR101247728B1 (ko) 의학용 혼합 용액의 조제를 위한 유연한 다-챔버 컨테이너
US4961495A (en) Plastic container having an easy-to-peel seal forming compartments
JP5299640B2 (ja) 複室容器
US20060093765A1 (en) Multi-compartment pouch having a frangible seal
US8118158B2 (en) Sealed storage bag of multiple compartment structure
JP4096200B2 (ja) 医療用複室容器及びこれを収容する収容袋
JP5418649B2 (ja) 複室容器
WO2008056605A1 (fr) Récipient à multiples chambres
KR20010032045A (ko) 선택적으로 확대 가능한 구획을 가지는 유연성 약제 용기및 그 제조 방법
JP5057172B2 (ja) 複室容器
JP2011194048A (ja) 医療用容器
JP4962733B2 (ja) 複室容器
JP6091156B2 (ja) 医療用容器、医療用容器の製造方法およびそれに用いられるシール金型
JP4535840B2 (ja) 医療用複室容器の製造方法
JP2007190161A (ja) 複室容器
JP4902149B2 (ja) 容器
JP2007260252A (ja) 医療用容器
JP2008061669A (ja) 複室容器
JP5223244B2 (ja) 複室容器
JP3932427B2 (ja) 医療用複室容器の製造方法
JP2007185418A (ja) 複室容器
JP4365948B2 (ja) 輸液バッグ
JP4962734B2 (ja) 複室容器
JP2008036336A (ja) 複室容器

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2007544218

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06823338

Country of ref document: EP

Kind code of ref document: A1